Project 2 - TB Translation as a Target
项目 2 - TB 翻译作为目标
基本信息
- 批准号:10242864
- 负责人:
- 金额:$ 50.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Anti-Bacterial AgentsAntibioticsBacteriaBiological AssayBiologyCapromycinCellsChemicalsCollaborationsComplexCryoelectron MicroscopyDevelopmentDrug TargetingEnergy MetabolismEnvironmentEnzymesGenomicsGenus MycobacteriumGoalsHumanInfectionLeadLinkLungMediatingMembraneMetabolicMitochondriaMycobacterium tuberculosisNucleic AcidsPathway interactionsPeptidesPhasePlayProcessProtein BiosynthesisProteinsProteomicsRNARegulationRegulatory PathwayRibosomesRoleSeriesStreptomycinStructureTechniquesTechnologyTranslationsWorkX-Ray Crystallographyantimicrobialbasecell growthdrug developmentinhibitor/antagonistmycobacterialnovelnovel therapeuticsprogramsscaffoldsmall molecule inhibitorstructural biologytranslation factortuberculosis drugs
项目摘要
Translation plays a key role in the survival of any cell and is a hub for many regulatory pathways that
control cellular growth. Due to this complexity, the ribosome has proven to be a vulnerable antibiotic
target and several existing antituberculous compounds block translation. We have capitalized on recent
advances in cryo-EM techniques to explore the unique structural aspects of the mycobacterial ribosome
that might alter antimicrobial efficacy and be exploited by new therapeutics.
翻译在任何细胞的生存中起着关键作用,是许多调控途径的枢纽
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES C SACCHETTINI其他文献
JAMES C SACCHETTINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES C SACCHETTINI', 18)}}的其他基金
Structure-based Discovery of Critical Vulnerabilities of Micobacteria
基于结构的微生物关键漏洞发现
- 批准号:
8711232 - 财政年份:2012
- 资助金额:
$ 50.26万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Micobacteria
基于结构的微生物关键漏洞发现
- 批准号:
8534693 - 财政年份:2012
- 资助金额:
$ 50.26万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
基于结构的分枝杆菌关键漏洞发现
- 批准号:
9755323 - 财政年份:2012
- 资助金额:
$ 50.26万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
基于结构的分枝杆菌关键漏洞发现
- 批准号:
10242858 - 财政年份:2012
- 资助金额:
$ 50.26万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
基于结构的分枝杆菌关键漏洞发现
- 批准号:
10456888 - 财政年份:2012
- 资助金额:
$ 50.26万 - 项目类别:
Admin Core TAMU (Sacchettini) Lead
管理核心 TAMU (Sacchettini) 负责人
- 批准号:
10456889 - 财政年份:2012
- 资助金额:
$ 50.26万 - 项目类别:
相似海外基金
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 50.26万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 50.26万 - 项目类别:
Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
- 批准号:
DP230102150 - 财政年份:2023
- 资助金额:
$ 50.26万 - 项目类别:
Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
- 批准号:
468567 - 财政年份:2022
- 资助金额:
$ 50.26万 - 项目类别:
Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 50.26万 - 项目类别:
Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10708102 - 财政年份:2022
- 资助金额:
$ 50.26万 - 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10587015 - 财政年份:2022
- 资助金额:
$ 50.26万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10581945 - 财政年份:2021
- 资助金额:
$ 50.26万 - 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
- 批准号:
2599490 - 财政年份:2021
- 资助金额:
$ 50.26万 - 项目类别:
Studentship
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10358855 - 财政年份:2021
- 资助金额:
$ 50.26万 - 项目类别:














{{item.name}}会员




